Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Celltech claims novel series of cell adhesion inhibitors

Aug. 26, 1999

Chemokine receptor antagonists discovered through LeukoSite-Kyowa Hakko collaboration

Aug. 26, 1999

NMI-377, an NO-donating diclofenac derivative with decreased GI side effects

Aug. 26, 1999

News from ACS: Abbott and Icos describe antiinflammatory ICAM-1 inhibitor

Aug. 25, 1999

Tanabe Seiyaku-Pharmacia & Upjohn collaboration provides new leads in inflammation research

Aug. 25, 1999

AdProTech and Avecia begin scale-up of APT-070

Aug. 25, 1999

ACS highlights: DuPont investigates dual MMP/TNF-alpha production inhibitors

Aug. 24, 1999

Korean researchers identify antiinflammatory/analgesic agent from native shrub extract

Aug. 24, 1999

Anika completes patient enrollment in Orthovisc phase III trial

Aug. 24, 1999

Fuji Pharmaceutical describes therapeutic activity of dual MMP/TACE inhibitors

Aug. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...